Delhi Chief Minister Arvind Kejriwal announced on Thursday that a plan had been formulated to vaccinate all adults against coronavirus within the next three months. (AFP)
NEW DELHI: The Delhi government will procure 67 lakh doses of Covishield vaccine from Serum Institute of India and the first tranche of three lakh doses will be delivered by May 3, official sources said on Thursday.
The Delhi government has also sought a supply schedule from the manufacturer for the remaining doses which are to be delivered over the next three months.
An official source said a purchase order has been issued in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at Pune-based Serum Institute of India (SII).
The Delhi government will procure 6.7 million doses of Covishield vaccine from Serum Institute of India and the first tranche of 300,000 shots will be delivered by May 3, official sources said on Thursday. The Delhi government has also sought a supply schedule from the manufacturer for the remaining doses which are to be delivered over the next three months. An official source said a purchase order has been issued in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII). Delhi Chief Minister Arvind Kejriwal announced on Thursday that a plan has been formulated to vaccinate all adults against coronavirus within the next three months.
Covaxin
Taking cue from Serum Insistute of India, Hyderbad-based Bharat Biotech on Thursday reduced price of its coronavirus vaccine, Covaxin, for states to Rs 400 per dose from Rs 600.
This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose. Recognising the enormous challenges in the public healthcare system, we have made Covaxin available to state governments at a price of 400/ dose , Bharat Biotech said in its announcement. The company is deeply concerned with the critical pandemic circumstances that India is facing at this time, it added. Serum Institute of India (SII) the maker of the most used COVID-19 vaccine in the country on Wednesday announced a cut in price of the jab it plans to sell to states to Rs 300 per dose from the earlier Rs 400.
Delhi COVID crisis: National capital to get 67 lakh Covishield doses from SII; oxygen shortage continues to haunt hospitals
An official source said a purchase order has been issued in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at Pune-based Serum Institute of India (SII).
Share Via Email
| A+A A-
A man walks past a mural that reads A Big Salute To Corona Warriors during ongoing COVID-19 lockdown in New Delhi . (Photo | PTI) By PTI
NEW DELHI: The Delhi government will procure 67 lakh doses of Covishield vaccine from Serum Institute of India and the first tranche of three lakh doses will be delivered by May 3, official sources said on Thursday.
Bharat biotech cuts Covaxin price to Rs 400 per dose for states telegraphindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from telegraphindia.com Daily Mail and Mail on Sunday newspapers.